Anna Rogojina
- Molecular Biology
- Oncology
- Ophthalmology top 10%
- Toxicology top 10%
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- John L. NitissBong Keun SongEldon E. GeisertAman SethMargarita MishinaK V ChalamSue Jinks-RobertsonKarin C. Nitiss
- Topics
- Cancer therapeutics and mechanisms (3 papers)Molecular Biology Techniques and Applications (2 papers)Retinal Diseases and Treatments (2 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistrySHILAP Revista de lepidopterología
- Partner nations
- United States
In The Last Decade
Anna Rogojina
8 papers receiving 228 citations
Peers
Comparison fields: 5 of 55
- Molecular Biology 177
- Oncology 50
- Ophthalmology 39
- Toxicology 20
- Radiology, Nuclear Medicine and Imaging 19
Countries citing papers authored by Anna Rogojina
This map shows the geographic impact of Anna Rogojina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rogojina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rogojina more than expected).
Fields of papers citing papers by Anna Rogojina
This network shows the impact of papers produced by Anna Rogojina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rogojina. The network helps show where Anna Rogojina may publish in the future.
Co-authorship network of co-authors of Anna Rogojina
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Rogojina. A scholar is included among the top collaborators of Anna Rogojina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Rogojina. Anna Rogojina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 2 | |
| 3 | 80 | |
| 4 | Bevacizumab therapy normalizes the pathological intraocular environment beyond neutralizing VEGF. | 8 |
| 5 | Multiplex immunoassay analysis of biomarkers in clinically accessible quantities of human aqueous humor. | 38 |
| 6 | 14 | |
| 7 | Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines. | 68 |
| 8 | Technical Brief Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines | 1 |
About Anna Rogojina
Anna Rogojina is a scholar working on Toxicology, Ophthalmology and Molecular Biology, having authored 8 papers that have together received 231 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (3 papers), Molecular Biology Techniques and Applications (2 papers) and Retinal Diseases and Treatments (2 papers). The work is most often cited by research in Toxicology (20 citations), Ophthalmology (39 citations) and Molecular Biology (177 citations). Anna Rogojina has collaborated with scholars based in United States. Frequent co-authors include John L. Nitiss, Bong Keun Song, Eldon E. Geisert, Aman Seth, Margarita Mishina, K V Chalam, Sue Jinks-Robertson, Karin C. Nitiss, James M. Berger and Yilun Sun. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.